RET-Positive Metastatic NSCLC
WCLC 2022 on the Phase II DOLPHIN Study: Durvalumab + Concurrent RT in Unresectable Locally Advanced NSCLC
By
WCLC 2022 Conference Coverage
FEATURING
Motoko Tachihara
By
WCLC 2022 Conference Coverage
FEATURING
Motoko Tachihara
Login to view comments.
Click here to Login
RET-Positive Metastatic NSCLC